XML 136 R36.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

12 Months Ended

Apr. 30, 2013

Schedule Of Equity Based Compensating Expense


		April 30, 2013		April 30, 2012		April 30, 2011
Direct costs of revenue	$	35	$	72	$	63
Product development		92		152		154
Selling, general, and administrative		466		697		743
Total equity-based compensation	$	593	$	921	$	960

Summary Of Remaining Unrecognized Compensation Expense


Fiscal Year Ending April 30,		Amount
2014	$	238
2015		142
2016		58
2017		3
Total	$	441

Summary Of Stock Option Activity


			Weighted-	Weighted-
			average	average remaining		Aggregate
			exercise	contractual		intrinsic
	Shares		price	term (in years)		value (1)
Outstanding at April 30, 2010	1,663,497	$	3.34	7.12	$	1,271,375
Granted	656,100		3.38
Exercised	(16,000)		1.28
Cancelled/expired	(151,414)		3.15
Outstanding at April 30, 2011	2,152,183		3.38	6.91		550,903
Granted	839,400		2.38
Exercised	(124,500)		1.40
Cancelled/expired	(234,968)		3.11
Outstanding at April 30, 2012	2,632,115		3.18	7.24		4,449
Granted	403,500		1.27
Exercised	-		-
Cancelled/expired	(1,221,016)		3.07
Outstanding at April 30, 2013	1,814,599		2.83	6.92		15,551



(1)		Aggregate intrinsic value is defined as the difference between the current market value and the exercise price and is estimated using the closing price of the Company’s common stock on the last trading day of the periods ended as of the dates indicated.

Summary Of Non-Vested Stock Option Activity


		Weighted-
		average
		fair
	Shares	value
Nonvested at April 30, 2012	1,005,036	1.61
Granted	403,500	1.01
Vested	(480,352)	1.52
Cancelled/expired	(480,668)	1.48
Nonvested at April 30, 2013	447,516	1.32

Schedule Of Options Outstanding By Exercise Price Range


	Options outstanding				Options exercisable
		Average		Weighted-			Weighted-
		remaining		average			average
	Number	contractual		exercise	Number		exercise
Range of exercise prices	outstanding	life (years)		price	outstanding		price
$ 0.86 - 1.26	235,000	8.80	$	1.16	15,000	$	1.10
1.34 - 1.80	181,500	8.78		1.42	132,352		1.42
1.85 - 2.15	183,194	7.63		1.94	129,943		1.94
2.25 - 2.55	122,000	4.04		2.51	122,000		2.51
2.60 - 2.60	288,707	6.01		2.60	283,344		2.60
2.65 - 2.86	9,625	6.49		2.69	8,541		2.69
2.90 - 2.90	217,500	8.01		2.90	159,128		2.90
3.00 - 3.46	90,962	6.93		3.13	71,263		3.15
3.56 - 3.56	190,762	7.01		3.56	153,186		3.56
3.75 - 6.70	295,349	5.09		5.29	293,077		5.31

Schedule Of Outstanding Warrants


Date of issuance	Number of warrants issued	Number of warrants outstanding		Exercise price	Expiration date
April 24, 2009	190,182	190,182	$	2.75	April 24, 2014
June 29, 2010	718,860	718,860		2.45	June 29, 2020

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References+ Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details